Position in SOLV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,945,730
+$1,236,997 QoQ
Shares Held
141,876
-4.6% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 875 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SOLV Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $155,026,127 across 35 Medical Instruments & Supplies names. SOLV ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ISRG |
Intuitive Surgical Inc
|
169,603 | $67,447,717 | |
| 2 | BDX |
Becton Dickinson & Co
|
162,416 | $24,578,409 | |
| 3 | RMD |
Resmed Inc
|
87,513 | $17,054,529 | |
| 4 | SOLV |
Solventum Corp
This page
|
141,876 | $10,945,730 | |
| 5 | WST |
West Pharmaceutical Services Inc
|
28,388 | $10,191,292 | |
| 6 | BAX |
Baxter International Inc
|
264,579 | $5,640,822 | |
| 7 | COO |
Cooper Companies, Inc.
|
55,097 | $3,951,001 | |
| 8 | ALC |
Alcon Inc
|
43,717 | $2,933,409 |
All Filings in SOLV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,945,730 | 141,876 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $9,708,733 | 148,679 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $12,507,869 | 157,848 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $12,583,083 | 172,371 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $14,103,656 | 185,966 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,152,715 | 199,273 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $15,909,422 | 240,833 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $18,452,648 | 264,668 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $16,275,295 | 307,778 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||